FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Elite Laboratories, Inc.

# FDA Approves Elite Laboratories' Generic Hydrocodone Bitartrate and Acetaminophen Elite Laboratories, Inc. received FDA approval for its generic formulation of hydrocodone bitartrate and acetaminophen oral tablets, potentially expanding the competitive landscape in the opioid pain management market and offering patients a more affordable alternative to branded versions. The approval could enable Elite Laboratories to capture market share in a significant therapeutic category, though growth may be tempered by ongoing regulatory scrutiny of opioid medications.